These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 21601003)

  • 1. Amyloid-β: the seeds of darkness.
    Fodero-Tavoletti MT; Villemagne VL; Rowe CC; Masters CL; Barnham KJ; Cappai R
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1247-51. PubMed ID: 21601003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease and the amyloid β-protein.
    Walsh DM; Teplow DB
    Prog Mol Biol Transl Sci; 2012; 107():101-24. PubMed ID: 22482449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
    Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
    Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease.
    Cerf E; Gustot A; Goormaghtigh E; Ruysschaert JM; Raussens V
    FASEB J; 2011 May; 25(5):1585-95. PubMed ID: 21266538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
    De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST
    FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-n oligomers as therapeutic targets of Alzheimer's disease.
    Ono K; Yamada M
    J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
    Matharu B; El-Agnaf O; Razvi A; Austen BM
    Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. I32E and V36K double mutation in beta2-sheet abrogates amyloid beta peptide toxicity.
    Subramanian S; Mishra PK; Bandopadhyay D
    Indian J Exp Biol; 2010 Nov; 48(11):1098-102. PubMed ID: 21117449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
    Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
    Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Compensatory function of transthyretin in Alzheimer's disease].
    Shwartsman AL; Sarantseva SV
    Tsitologiia; 2011; 53(10):772-7. PubMed ID: 22232933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.
    Tõugu V; Tiiman A; Palumaa P
    Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations.
    Tseng BP; Esler WP; Clish CB; Stimson ER; Ghilardi JR; Vinters HV; Mantyh PW; Lee JP; Maggio JE
    Biochemistry; 1999 Aug; 38(32):10424-31. PubMed ID: 10441137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrillar seeds alleviate amyloid-β cytotoxicity by omitting formation of higher-molecular-weight oligomers.
    Wu WH; Liu Q; Sun X; Yu JS; Zhao DS; Yu YP; Luo JJ; Hu J; Yu ZW; Zhao YF; Li YM
    Biochem Biophys Res Commun; 2013 Sep; 439(3):321-6. PubMed ID: 24012671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
    Cerf E; Sarroukh R; Tamamizu-Kato S; Breydo L; Derclaye S; Dufrêne YF; Narayanaswami V; Goormaghtigh E; Ruysschaert JM; Raussens V
    Biochem J; 2009 Jul; 421(3):415-23. PubMed ID: 19435461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing and trapping a sensitive conformation: amyloid-β fibrils, oligomers, and dimers.
    Fawver JN; Duong KT; Wise-Scira O; Petrofes Chapa R; Schall HE; Coskuner O; Zhu X; Colom LV; Murray IV
    J Alzheimers Dis; 2012; 32(1):197-215. PubMed ID: 22785403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do amyloid β-associated factors co-deposit with Aβ in mouse models for Alzheimer's disease?
    Timmer NM; Kuiperij HB; de Waal RM; Verbeek MM
    J Alzheimers Dis; 2010; 22(2):345-55. PubMed ID: 20847441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Hardy J; Selkoe DJ
    Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.